mRNA |
pifithrin-mu |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
7e-06 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
8e-06 |
mRNA |
selumetinib:BRD-A02303741 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.17 |
8e-06 |
mRNA |
MK 1775 |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
9e-06 |
mRNA |
manumycin A |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
1e-05 |
mRNA |
GSK1120212 |
CTRPv2 |
pan-cancer |
AAC |
-0.25 |
1e-05 |
mRNA |
Cytarabine |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
1e-05 |
mRNA |
decitabine |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
1e-05 |
mRNA |
selumetinib:tretinoin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.18 |
1e-05 |
mRNA |
AZD1480 |
CTRPv2 |
pan-cancer |
AAC |
0.26 |
2e-05 |